New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
09:39 EDTWYNN, C, STSI, TXN, AA, TSLA, AAPL, NFLX, FB, GILDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL STSI GILD TSLA C FB AA WYNN NFLX TXN
News For AAPL;STSI;GILD;TSLA;C;FB;AA;WYNN;NFLX;TXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
April 6, 2015
10:23 EDTAAPLApple Maps searches no longer showing just Yelp, AppleInsider reports
Searches on Apple (AAPL) Maps, which previously relied solely on Yelp (YELP) to provide reviews for local search, are now pulling results from TripAdvisor (TRIP) and Priceline's (PCLN) Booking.com, AppleInsider reported yesterday. Neither TripAdvisor or Booking.com are listed as sources on Apple's official Maps attribution webpage, but reviews with links to their respective webpages and apps are now appearing in Maps queries, the blog added. Shares of Yelp are down 1% to $46.67 in early trading. Reference Link
10:15 EDTTSLATesla breaks higher, levels to watch
Subscribe for More Information
09:36 EDTAAPL, TSLAActive equity options trading on open
Subscribe for More Information
09:22 EDTTSLAOn The Fly: Pre-market Movers
HIGHER: Uniqure (QURE), up 44.2% following strategic collaboration with Bristol-Myers (BMY)... Cytori Therapeutics (CYTX), up 22.4% after Lorem Vascular receives regulatory clearance in China... Curis (CRIS), up 8.5% after FDA grants orphan drug designation to CUDC-907 for the treatment of Diffuse Large B-Cell Lymphoma... Capnia (CAPN), up 5.9% after being awarded a $220,000 NIH grant... Tesla (TSLA), up 3.8% after reporting first quarter deliveries up 55% to 10,030 cars... Ariad (ARIA), up 3.4% following approval of Iclusig in Canada... Lumber Liquidators (LL), up 3.1% after being upgraded to Outperform from Market Perform at Raymond James. LOWER: Magnum Hunter (MHR), down 8.9% after being downgraded to Hold from Buy at Wunderlich... Herbalife (HLF), down following CNBC report that federal law enforcement agencies contacted the company regarding its business practices... Qualcomm (QCOM), down 2.2% following a Wall Street Journal report that the Samsung (SSNLF) Galaxy S6 did not have a Qualcomm LTE modem... Skyworks (SWKS), down 2.1% after being downgraded to Equal Weight from Overweight at Stephens.
09:02 EDTTSLATesla trades up on Q1 deliveries update, levels to watch
Subscribe for More Information
08:41 EDTTSLARW Baird calls Tesla favorite pick after Q1 deliveries beat expectations
Baird said they would be buyers of Tesla and the stock remains their favorite pick following the company's announcement of Q1 deliveries of 10,030 vehicles, which beat both the Street and firm's estimates. The firm also noted the company's reporting change to "within three days" of the end of the quarter, as it erases the month of speculation between quarter end and reporting. Baird reiterated its Outperform rating and $275 price target on Tesla shares.
08:24 EDTTSLATesla Q1 deliveries not impressive, says BofA/Merrill
Subscribe for More Information
07:42 EDTAAAlcoa April volatility elevated into Q1 and outlook
Subscribe for More Information
07:36 EDTGILDGilead Q1 HCV revenue poised to beat expectations, says RBC Capital
After analyzing weekly prescription data, RBC Capital believes that Gilead's weekly hepatitis C prescriptions are tracking towards $3.5B-$3.6B of revenue from hepatitis C drugs for Q1, versus the consensus outlook of about $2.6B. The firm keeps an Outperform rating on Gilead.
07:29 EDTAAPLApple Watch cannot launch in Switzerland due to patent issue, Reuters says
Subscribe for More Information
06:20 EDTAAPLGarmin downgraded to Sell from Buy at Citigroup
Citigroup analyst Jeremy David downgraded Garmin two notches to Sell from Buy saying competitive pressures are likely to stall the growth of the company's GPS fitness watch business. He also thinks revenue trends in Garmin's Outdoor segment could disappoint as the year progresses. David expects Garmin to miss consensus earnings and revenue expectations in Q1 and views the Apple (AAPL) Watch launch as another potential negative catalyst for shares. He cut his price target for the stock to $42 from $68. Shares of the navigation and information device maker closed Thursday down 58c to $46.49 after Goldman Sachs downgraded the stock Neutral from Buy.
06:11 EDTAAPLSamsung expected to win A9 chip orders for next iPhone, Bloomberg reports
Subscribe for More Information
06:03 EDTFBUber hires Facebook's Joe Sullivan as Chief Security Officer
Subscribe for More Information
05:15 EDTWYNNElaine Wynn recommends holders 'WITHHOLD' their votes for company nominees
Elaine Wynn, co-founder, board member and third-largest stockholder of Wynn Resorts, commented on the recommendation from Institutional Shareholder Service, or ISS, that Wynn stockholders WITHHOLD their vote for management's nominees for the Wynn Resorts board at the upcoming 2015 Annual Meeting. In response, Elaine Wynn has issued the following statement: "I believe the stockholders of Wynn Resorts deserve better than the choices presented to them by the company this proxy season, and the only way to achieve meaningful value creation for my fellow stockholders is to vote the GOLD card FOR my reelection at the upcoming Annual Meeting. The ISS report raises a number of important concerns about the performance of the board. I firmly believe my judgment, considerable experience, important diversity and willingness to challenge the status quo makes me the best positioned candidate to guard and grow stockholders' interest and identify additional diverse candidates with independent voices, As the third largest stockholder, my interests inextricably align with my fellow stockholders, giving me a unique perspective on protecting and increasing the value of our collective investment in the future. The company, by contrast, continues to disseminate comments designed to obscure the truth, as they did tonight in their statement on the ISS recommendation, and it is my hope that other stockholders recognize my value and vote FOR my reelection using the GOLD proxy card."
05:10 EDTWYNNISS recommends Wynn Resorts holders vote against Elaine Wynn
Subscribe for More Information
April 5, 2015
17:26 EDTTSLATesla direct sales blocked in West Virginia, The Verge says
Subscribe for More Information
16:56 EDTAAPL, FBEU considers major probe into Internet platforms, WSJ says
Subscribe for More Information
16:29 EDTNFLXNetflix's 'House of Cards' to return for fourth season
Netflix's official twitter account for "House of Cards" tweeted on Thursday the following: "I will leave a legacy." Along with the tweet was a picture with an upside down American flag that said, "Season 4 coming in 2016." Reference Link
14:43 EDTGILDActavis seeks FDA approval to market generic version of Gilead's Letairis
Actavis (ACT) on Friday, confirmed that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg. Actavis' ANDA product is a generic version of Gilead Science's (GILD) Letairis, which is a treatment for pulmonary arterial hypertension. Gilead Sciences and Royalty Pharma Collection Trust filed suit against Actavis on April 1, in the U.S. District Court for the District of Delaware seeking to prevent Actavis from commercializing its ANDA product prior to the expiration of U.S. Patent number RE42,462. The lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Actavis' ANDA for up to 30 months from the date the plaintiffs received notice of Actavis' ANDA filing or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities. Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Letairis and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity. For the 12 months ending December 31, Letairis had global sales of approximately $595M, according to Gilead.
09:10 EDTAAPLApple Watch to be sold by appointment only, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use